Search Results

You are looking at 121 - 130 of 508 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Rajmohan Murali, Deborah F. Delair, Sarah M. Bean, Nadeem R. Abu-Rustum, and Robert A. Soslow

data from clinicopathologic and molecular genetic studies, pathology will continue to play a central role in diagnosis, prognostic assessment, and treatment planning. Evolution of Surgical-Pathologic Staging Most patients with endometrial cancer

Full access

Francois G. El Kamar and Lauren E. Abrey

Paulus W . Classification, pathogenesis and molecular pathology of primary CNS lymphomas . J Neurooncol 1999 ; 43 : 203 – 208 . 3 Schlegel U Schmidt-Wolf IG Deckert M . Primary CNS lymphoma: clinical presentation, pathological

Full access

Douglas E. Wood

resources in radiology, pulmonary medicine, thoracic surgery, and pathology, along with a disciplined and multidisciplinary approach to nodule management. In the NLST, 96% of lung nodules found were ultimately determined to be false-positives, and 24% of

Full access

Srinivas K. Tantravahi, and Theresa L. Werner

tobacco, alcohol, or illicit drugs. In June 2011 she underwent laparoscopic total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymphadenectomy. Pathology revealed FIGO grade 1–2 endometrioid adenocarcinoma measuring 4.2 × 3

Full access

Justin Famoso, Gerald Lemole, Srinath Sundararajan, and Baldassarre Stea

residual tumor remaining postoperatively measuring 2.9 × 2.6 × 2.4 cm on MRI ( Figure 1B ). Gross pathology revealed a dark red-brown friable mass. Microscopic evaluation showed nests of pleomorphic cells with hyperchromatic nuclei and melanotic pigment

Full access

Daniel L. Hertz and Vaibhav Sahai

.1016/S1470-2045(18)30686-7 15. Sepulveda AR , Hamilton SR , Allegra CJ , . Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association

Full access

Presenter: Sandy Srinivas

compared findings with biopsies. 4 Cohort A included 268 men with high-risk prostate cancer treated with 18 F-DCFPyL (safety set); of these, 252 underwent PET/CT imaging and had evaluable surgical pathology (evaluable set). Cohort B comprised 117 men with

Full access

Kathleen N. Moore and Joan L. Walker

undetermined significance: Am J Obstet Gynecol 2003 ; 188 : 1383 – 1392 . 15 Cox JT . The clinician's view role of human papillomavirus testing in the American Society for Colposcopy and cervical pathology guidelines for the management of

Full access

Michael R. Loken and Denise A. Wells

. Monomyeloid cell differentiation in normal bone marrow assessed by multidimensional flow cytometry . In: Burger G, Oberholzer M, Vooijs GP, eds. Advances in Analytical Cellular Pathology . Amsterdam : Excerpta Medica ; 1990 : 211 – 212 . 7

Full access

Steven Sorscher

HER2-negative (Group 2, HER2-negative). The panel suggested that pathology reports include the statement “evidence is limited on the efficacy of HER2-targeted therapy in the small subset of cases with a HER2 / CEP17 ratio of ≥2 and an average HER2